Holda Awah Anagho-Mattanovich

Holda Awah Anagho-Mattanovich is a researcher at the Novo Nordisk Foundation Center for Protein Research within the Faculty of Health and Medical Sciences at the University of Copenhagen. She works across both the Nielsen Group and Olsen Group, focusing on advanced proteomics research with particular expertise in ADP-ribosylation and DNA damage response mechanisms.

• Current Position: Researcher at Novo Nordisk Foundation Center for Protein Research
• Institution: University of Copenhagen
• Research Groups: Nielsen Group and Olsen Group
• Location: Blegdamsvej 3B, 2200 København N

Dr. Anagho-Mattanovich's research focuses on the intersection of proteomics, cancer biology, and DNA repair mechanisms. Her work primarily investigates ADP-ribosylation processes, particularly in the context of breast cancer with BRCA mutations. She employs multi-omics approaches to understand cellular responses to DNA damage and therapeutic interventions like PARP inhibitors. Her research has significant implications for understanding drug resistance mechanisms and developing novel cancer therapeutics targeting DNA repair pathways.

Analysis of her recent publications reveals a strong focus on advanced proteomic techniques to characterize post-translational modifications, particularly ADP-ribosylation. Her work spans methodological development in mass spectrometry as well as application to cancer biology, with emphasis on breast cancer models. She frequently collaborates with multiple research groups across the Center for Protein Research, contributing to both technical methodology papers and disease-focused biological studies.

Dr. Anagho-Mattanovich has established herself as a contributor to the field of proteomics with several high-impact publications in the past two years. Her collaborative approach is evident through her co-authorship on diverse projects spanning from methodological developments to cancer biology studies.

Her research activities include active participation in multi-institutional collaborations focused on advancing proteomic methodologies and their application to cancer research. She works within the state-of-the-art facilities at the Novo Nordisk Foundation Center for Protein Research, which provides cutting-edge instrumentation for mass spectrometry-based proteomics research.